期刊
CURRENT TOPICS IN MEDICINAL CHEMISTRY
卷 6, 期 4, 页码 317-329出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156802606776287072
关键词
-
资金
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056385, U01AI061139, P01AI055789] Funding Source: NIH RePORTER
- NIAID NIH HHS [AI061139, AI056385, AI055789] Funding Source: Medline
Proteases are essential enzymes which regulate physiological processes such as inflammation, infection, fertilization, allergic reactions, cell growth and death, blood clotting, tumor growth and bone remodeling. The protease family consists of six major classes of enzymes which are aspartic-, serine-, cysteine-, threonine-, glutamic-, and metalloproteases, all which are implicated in disease propagation. Therefore, protease inhibitors have been of great interest as possible targets for the development of novel therapies. Although, many protease inhibitors have followed a structural design based on either a peptidic or peptidomimetic backbone, other chemical scaffolds have recently emerged. Utilizing structure- and fragment-based design guided by X-ray crystallography, NMR spectroscopy, computational and/or extended tethering approaches, potential non-peptidic therapeutic agents could be identified. In this review, we will report on the recent developments of nonpeptidic cysteine- and metallo- protease inhibitors, focusing on their design by using such strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据